NOVAVAX INC's ticker is NVAXXXXX and the CUSIP is 670002104. A total of 1 filers reported holding NOVAVAX INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2018 | $21,000 | -27.6% | 11,214 | -27.9% | 0.00% | 0.0% |
Q3 2018 | $29,000 | +38.1% | 15,561 | 0.0% | 0.00% | 0.0% |
Q2 2018 | $21,000 | -34.4% | 15,561 | +1.1% | 0.00% | 0.0% |
Q1 2018 | $32,000 | +68.4% | 15,399 | 0.0% | 0.00% | 0.0% |
Q4 2017 | $19,000 | +26.7% | 15,399 | +15.5% | 0.00% | 0.0% |
Q3 2017 | $15,000 | -89.2% | 13,334 | -89.0% | 0.00% | -83.3% |
Q2 2017 | $139,000 | -9.7% | 120,775 | +0.4% | 0.01% | -14.3% |
Q1 2017 | $154,000 | -6.7% | 120,320 | -7.9% | 0.01% | -12.5% |
Q4 2016 | $165,000 | -46.6% | 130,691 | -12.0% | 0.01% | -46.7% |
Q3 2016 | $309,000 | -72.2% | 148,443 | -2.9% | 0.02% | -72.2% |
Q2 2016 | $1,112,000 | +35.1% | 152,936 | -4.1% | 0.05% | +25.6% |
Q1 2016 | $823,000 | -50.2% | 159,406 | -19.0% | 0.04% | -44.9% |
Q4 2015 | $1,651,000 | +18.4% | 196,760 | -0.2% | 0.08% | -1.3% |
Q3 2015 | $1,394,000 | +1664.6% | 197,157 | +1045.9% | 0.08% | +2533.3% |
Q2 2014 | $79,000 | +8.2% | 17,205 | +6.2% | 0.00% | 0.0% |
Q1 2014 | $73,000 | – | 16,200 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Parametrica Management Ltd | 61,882 | $438,000 | 2.76% |
BB BIOTECH AG | 8,330,000 | $58,893,000 | 1.87% |
Cormorant Asset Management, LP | 1,600,000 | $11,312,000 | 1.81% |
HARVEY CAPITAL MANAGEMENT INC | 623,950 | $4,411,000 | 1.76% |
WILLIAM HARRIS INVESTORS INC | 488,666 | $3,455,000 | 0.98% |
Eventide Asset Management | 2,097,500 | $14,829,000 | 0.86% |
AWM Investment Company, Inc. | 400,000 | $2,828,000 | 0.55% |
NORTHPOINTE CAPITAL LLC | 507,344 | $3,587,000 | 0.47% |
Rock Springs Capital Management LP | 715,000 | $5,055,000 | 0.41% |
Opus Point Partners Management, LLC | 100,000 | $707,000 | 0.39% |